SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-323812
Filing Date
2021-11-09
Accepted
2021-11-09 07:53:25
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d132524d10q.htm   iXBRL 10-Q 1338348
2 EX-31.1 d132524dex311.htm EX-31.1 6439
3 EX-31.2 d132524dex312.htm EX-31.2 6955
4 EX-32 d132524dex32.htm EX-32 6533
  Complete submission text file 0001193125-21-323812.txt   6669360

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA itci-20210930.xsd EX-101.SCH 42867
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20210930_cal.xml EX-101.CAL 36451
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20210930_def.xml EX-101.DEF 266622
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20210930_lab.xml EX-101.LAB 408516
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20210930_pre.xml EX-101.PRE 375364
10 EXTRACTED XBRL INSTANCE DOCUMENT d132524d10q_htm.xml XML 1188919
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 211389926
SIC: 2834 Pharmaceutical Preparations